Wichmann G C, Körber R, Fölsch U R
Arzneimittelforschung. 1985;35(8):1307-10.
The effect of 2-[2-(5-methyl-4-imidazolmethylthio)-ethyl-amino]-5-(3,4- methylendioxybenzyl)-4-pyrimidone dihydrochloride (oxmetidine) as continuous i.v. infusion over 11 1/2 h was tested with the doses of 12.5, 25 and 50 mg/h following an infusion of 200 mg over 30 min. In eight healthy male volunteers the parameters of gastric acid secretion were examined over 12 h as well as plasma oxmetidine and serum gastrin concentrations. Basal acid secretion was dose-dependently reduced from 53.1 mmol/12 h to minimally 3.2 mmol/12 h. A pH greater than or equal to 5 was reached for each volunteer under each dose, but even with the highest dose (50 mg/h) of oxmetidine a suppression of acid secretion up to the end of the 12-h experiment could not be observed.
在30分钟内输注200毫克2-[2-(5-甲基-4-咪唑甲基硫基)-乙氨基]-5-(3,4-亚甲二氧基苄基)-4-嘧啶酮二盐酸盐(奥美替丁)后,以12.5、25和50毫克/小时的剂量进行11.5小时的连续静脉输注,测试其效果。在8名健康男性志愿者中,在12小时内检查胃酸分泌参数以及血浆奥美替丁和血清胃泌素浓度。基础酸分泌从53.1毫摩尔/12小时剂量依赖性地降至最低3.2毫摩尔/12小时。在每个剂量下,每位志愿者的pH值均达到或高于5,但即使使用最高剂量(50毫克/小时)的奥美替丁,在12小时实验结束前也未观察到酸分泌受到抑制。